Back to search

Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis

Data up to Jan 2025

Published2007
Citations59
References56

Total Citations Per Year

Abstract

References (56)

Measuring inconsistency in meta-analyses

2003 • 53,662 citations

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1998 • 3,578 citations

Systematic Reviews in Health Care : Meta-Analysis in Context

2000 • 2,282 citations

Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder

1991 • 1,896 citations

Prevalence and Treatment of Mental Disorders, 1990 to 2003

2005 • 1,864 citations

Systematic Reviews in Health Care

2001 • 1,637 citations

Imputing missing standard deviations in meta-analyses can provide accurate results

2005 • 1,378 citations

Distributed Disturbances in Brain Structure and Function in Schizophrenia

2000 • 964 citations

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

2001 • 818 citations

Multiple Recurrences of Major Depressive Disorder

2000 • 788 citations

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis

2002 • 544 citations

Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration Database

2002 • 453 citations

Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review

2006 • 439 citations

Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study

1990 • 390 citations

Past, Present, and Future Directions for Defining Optimal Treatment Outcome in Depression

2003 • 387 citations

Meta-analytical studies on new antidepressants

2001 • 353 citations

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia

1994 • 301 citations

Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study

1986 • 294 citations

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

2003 • 263 citations

Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder

2005 • 261 citations

Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study

2005 • 238 citations

Once-Daily Venlafaxine Extended Release (XR) Compared With Fluoxetine in Outpatients With Depression and Anxiety

1999 • 237 citations

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

2006 • 227 citations

A Double-Blind Comparison of Escitalopram and Venlafaxine Extended Release in the Treatment of Major Depressive Disorder

2004 • 186 citations

A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

2004 • 179 citations

A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression

1999 • 165 citations

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients

1996 • 156 citations

The Efficacy of Antidepressants in the Treatment of Late-Life Depression

2005 • 145 citations

A Double-Blind, Placebo-Controlled Study of Venlafaxine and Fluoxetine in Geriatric Outpatients With Major Depression

2006 • 141 citations

A Randomized, Placebo-Controlled, Dose-Response Trial of Venlafaxine Hydrochloride in the Treatment of Major Depression

1998 • 136 citations

Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression

2000 • 135 citations

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials

2006 • 131 citations

Randomized Trial of Sertraline Versus Venlafaxine XR in Major Depression

2005 • 124 citations

Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: A meta-analysis of randomized controlled trials

1999 • 110 citations

Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy

2005 • 107 citations

Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopram

2004 • 105 citations

Randomized, Double-Blind Comparison of Venlafaxine and Fluoxetine in Outpatients With Major Depression

1998 • 98 citations

Randomized, Double-Blind Comparison of Venlafaxine and Sertraline in Outpatients With Major Depressive Disorder

2000 • 94 citations

Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal function after living kidney donation

2006 • 87 citations

Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia

2000 • 83 citations

Is the Cutoff to Define Remission on the Hamilton Rating Scale for Depression Too High?

2005 • 76 citations

A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients

2005 • 64 citations

The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia

2000 • 64 citations

"Wish Bias" in Antidepressant Drug Trials?

2004 • 61 citations

A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder

2006 • 49 citations

Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression

2006 • 48 citations

Achieving gains beyond response

2002 • 41 citations

Efficacy and tolerability of venlafaxine and fluoxetine in outpatients with major depression

1998 • 34 citations

P.1.083 A comparison of once-daily venlafaxine XR and paroxetine in depressed outpatients treated in general practise

1997 • 34 citations

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo

2005 • 33 citations

Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors

2002 • 31 citations

Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition

2005 • 31 citations

Weighing the pros and cons for composite outcomes in clinical trials

2007 • 30 citations

Once-daily extended release (XR) veniafaxine versus paroxetine in outpatients with major depression

1997 • 11 citations

Venlafaxine versus fluoxetine in the treatment of depressed patients with concomitant anxiety

1999 • 5 citations

Venlafaxine for major depression More evidence that risks outweigh benefits for most patients

2007 • 2 citations

Cited By (0)

Loading...